IL-27 elicited antibodies: A novel means to control persistent Arenavirus infection
IL-27 elicited antibodies: A novel means to control persistent Arenavirus infection
批准号:
9204389
负责人:
John Ross Teijaro
金额:
$48.13万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-01-15 至 2020-12-31
关键词:
AcuteAffectAfricaAnimal ModelAntibodiesAntiviral AgentsApplications GrantsArenaviridae InfectionsArenavirus InfectionsB-LymphocytesBiological Response ModifiersCD8-Positive T-LymphocytesCell physiologyConeDataDefectDevelopmentDiseaseDisease OutbreaksEbola virusEnvironmentEquilibriumFamilyFunctional disorderGenerationsHealth Care CostsHelper-Inducer T-LymphocyteHumanIgG1ImmuneImmune responseImmunoglobulin GImmunosuppressive AgentsInfectionInfection ControlInterleukin-10Interleukin-6LifeLightLymphocytic choriomeningitis virusModelingMusNatureOutcomePlasmaPlayProductionPropertyPublic HealthRoleSignal TransductionStudy modelsT cell responseT-LymphocyteTimeTranslatingVaccine DesignViralViral AntibodiesVirusVirus Diseasesadaptive immune responseantiviral immunitybasecombatcytokineexhaustionin vivomemberneglectnovelpublic health relevancepurgeresponsetherapy design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Persistent virus infections cause disease in hundreds of millions of people and exert constant strain on the global economy due to healthcare costs. While progress has been made towards understanding mechanisms that allow viruses to persist, therapies to control persistent viruses are not optimal due an incomplete understanding of the factors involved in virus persistence. One common theme that accompanies virus persistence is an exhaustive or hypo-responsive state of adaptive immune response. This phenomenon was first described using the staple animal model for studying virus persistence, Lymphocytic Choriomeningitis Virus (LCMV), in its natural mouse host and extended to human persistent infections. Using this model, it was revealed that a balance between positive and negative immune regulatory molecules is essential to purge virus infection. One of the most extensively studied mechanisms contributing to virus persistence has been T cell exhaustion, which is potentiated by negative immune regulatory molecules such as IL-10 and PD-1. Interestingly, the absence of two positive immune regulatory molecules, IL-6 and IL-21, result in the inability to control persistent virus infection. These molecules are known to be important for B cell function. However, studies on whether B cells also control persistent virus infection have been neglected and their role remains unknown. A newly discovered member of the IL-6 family, IL-27, modulates both B and T cell responses during infection. However, few studies have examined how IL-27 affects antiviral immune responses. I began studying how IL-27 deletion affects the outcome of both acute and persistent LCMV infection. I made the observation that IL-27-deficiency resulted in prolonged LCMV clone-13 persistence. Prolonged virus persistence in IL-27-/- mice correlated with defects in both T and B cell responses. Virus specific T cells in IL-
27-/- mice displayed exacerbated T cell exhaustion following clone-13 infection. Moreover, I discovered that IL- 27-/- mice made elevated levels of IgG1 with minimal production of IgG2a, compared to predominant production of IgG2a in IL-27+/+ hosts. I further demonstrated that development of plasma B cells (the major antibody producers) and anti-LCMV IgG production is required to control clone-13 infection, indicating that antibody likely plays an important role in controlling persistent virus infection. This grant proposal aims to elucidate the mechanisms by which IL-27-deficiency leads to prolonged LCMV persistence. The aims are focused on understanding how IL-27 contributes to altered antiviral T and B cell responses and whether IL-27 signaling on T or B cells is essential to purge persistent LCMV infection. The absence of IgG2a production during persistent virus infection in IL-27-deficient mice suggests that IL-27- dependent induction of IgG2a may be essential to control persistent virus infection. The possibility that a specific antibody isotype may be essential to purge persistent virus infection i novel and will be investigated within this proposal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Animal and Organoid Model Core
-
批准号:10514322
-
项目类别:
-
资助金额:$365.76万
-
财政年份:2022
-
负责人:John Ross Teijaro
-
依托单位:
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.
-
批准号:10445313
-
项目类别:
-
资助金额:$53.76万
-
财政年份:2021
-
负责人:John Ross Teijaro
-
依托单位:
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.
-
批准号:10316578
-
项目类别:
-
资助金额:$53.76万
-
财政年份:2021
-
负责人:John Ross Teijaro
-
依托单位:
The role of IL-27 in sustaining the exhausted CD8 T cell response to persistent infection and cancer.
-
批准号:10650747
-
项目类别:
-
资助金额:$54.82万
-
财政年份:2021
-
负责人:John Ross Teijaro
-
依托单位:
Engineer Immune Cells via Chemoenzymatic Glycan Editing
-
批准号:10350593
-
项目类别:
-
资助金额:$94.43万
-
财政年份:2019
-
负责人:John Ross Teijaro
-
依托单位:
Engineer Immune Cells via Chemoenzymatic Glycan Editing
-
批准号:10578671
-
项目类别:
-
资助金额:$94.43万
-
财政年份:2019
-
负责人:John Ross Teijaro
-
依托单位:
Novel Strategies for Controlling Persistent Viral Infection
-
批准号:9077410
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2016
-
负责人:John Ross Teijaro
-
依托单位:
Novel Strategies for Controlling Persistent Viral Infection
-
批准号:9248857
-
项目类别:
-
资助金额:$48.13万
-
财政年份:2016
-
负责人:John Ross Teijaro
-
依托单位:
The Role of IL-27 in Controlling Persistent Viral Infection
-
批准号:8897666
-
项目类别:
-
资助金额:$47.38万
-
财政年份:2014
-
负责人:John Ross Teijaro
-
依托单位:
海外基金